INSTITUTE OF LIVER AND BILIARY SCIENCES

🇮🇳India

Country: 🇮🇳India

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Evaluation of Low-dose Albumin and Midodrine Versus Midodrine Alone in Outcome of Recurrent Ascites in Patients With Decompensated Cirrhosis.

Not Applicable

Not yet recruiting

Conditions: Decompensated Cirrhosis

Interventions: Drug: Midodrine
Drug: Albumin
Other: Standard of Care

First Posted Date: 2024-02-07

Last Posted Date: 2024-02-07

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 100

Registration Number: NCT06245590

Locations: 🇮🇳
Asian Institute of Gastroenterology, Somajiguda, Hyderabad, India
🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Efficacy and Safety of SBRT Combined With Atezolizumab Plus Bevacizumab vs Atezolizumab Plus Bevacizumab in Treating Unresectable Advance Hepatocellular Carcinoma.

Not yet recruiting

Conditions: Advanced Hepatocellular Carcinoma

Interventions: Other: No intervention

First Posted Date: 2024-02-06

Last Posted Date: 2024-02-06

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 40

Registration Number: NCT06244446

Locations: 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

Efficacy of Rifaximin vs Norfloxacin for Secondary Prophylaxis of SBP (NORRIF Trial)

Not Applicable

Not yet recruiting

Conditions: Spontaneous Bacterial Peritonitis

Interventions: Drug: Rifaximin
Drug: Norfloxacin

First Posted Date: 2024-01-10

Last Posted Date: 2024-01-10

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 280

Registration Number: NCT06199843

Locations: 🇮🇳
Dr Jaya Benjamin, New Delhi, Delhi, India

GUT MICROBIOTA IN CHILDREN WITH AUTOIMMUNE LIVER DISEASE AND ITS EFFECT ON TREATMENT RESPONSE

Not yet recruiting

Conditions: Autoimmune Diseases

Interventions: Other: No intervention

First Posted Date: 2023-12-27

Last Posted Date: 2023-12-27

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 24

Registration Number: NCT06183190

Locations: 🇮🇳
Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India

Efficacy of Baclofen Vs Naltrexon in Achieving & Maintaining Abstinence in Alcohol Dependence.

Not Applicable

Not yet recruiting

Conditions: Alcohol Liver Disease

Interventions: Drug: Naltrexon
Drug: Baclofen

First Posted Date: 2023-12-19

Last Posted Date: 2023-12-19

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 110

Registration Number: NCT06175507

Locations: 🇮🇳
Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India

Role of Exercise in Chronic Liver Disease Patients Undergoing Liver Transplantation

Not Applicable

Not yet recruiting

Conditions: Chronic Liver Disease and Cirrhosis
Frailty

Interventions: Behavioral: Supervised aerobic and resistance exercises
Dietary Supplement: Dietary supplementation

First Posted Date: 2023-12-08

Last Posted Date: 2023-12-08

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 60

Registration Number: NCT06163001

Locations: 🇮🇳
Institute of Liver and Biliary Sciences, New Delhi, Delhi, India

Role of Extended Low Dose Prednisolone in Achieving Clinical and Biochemical Remission in Steroid Responsive Severe Alcoholic Hepatitis

Not Applicable

Not yet recruiting

Conditions: Severe Alcoholic Hepatitis

Interventions: Drug: Prednisolone
Drug: Placebo
Other: Standard Medical therapy

First Posted Date: 2023-12-04

Last Posted Date: 2023-12-04

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 150

Registration Number: NCT06155760

Locations: 🇮🇳
Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India

Rotational Thromboelastometry [ROTEM] vs Thromboelastography [TEG] Guided Blood Component Use in Patients With Cirrhosis of Liver With Non-variceal Bleeding.

Not Applicable

Recruiting

Conditions: Liver Cirrhosis

Interventions: Diagnostic Test: ROTEM
Diagnostic Test: Thromboelastography

First Posted Date: 2023-12-01

Last Posted Date: 2024-08-07

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 80

Registration Number: NCT06153082

Locations: 🇮🇳
Dr Saurav Paul, New Delhi, Delhi, India

To Compare the Safety and Efficacy of Dapagliflozin Plus Metformin Versus Sitagliptin Plus Metformin for Treatment of Diabetes in Patients With Compensated and Stable Decompensated Cirrhosis

Not Applicable

Not yet recruiting

Conditions: Decompensated Cirrhosis
Compensated Cirrhosis

Interventions: Drug: Metformin
Drug: Sitagliptin
Drug: Dapagliflozin

First Posted Date: 2023-11-27

Last Posted Date: 2023-12-08

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 240

Registration Number: NCT06147518

Locations: 🇮🇳
Dr Rakesh Kumar Jagdish, New Delhi, Delhi, India

Lactate Kinetics as a Predictor of Survival in ACLF With Septic Shock

Not yet recruiting

Conditions: Acute on Chronic Liver Failure

First Posted Date: 2023-11-03

Last Posted Date: 2023-11-03

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 100

Registration Number: NCT06116305

Locations: 🇮🇳
Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India

Home Terms & Conditions Privacy Policy